ZA858456B - Polypeptide - Google Patents

Polypeptide

Info

Publication number
ZA858456B
ZA858456B ZA858456A ZA858456A ZA858456B ZA 858456 B ZA858456 B ZA 858456B ZA 858456 A ZA858456 A ZA 858456A ZA 858456 A ZA858456 A ZA 858456A ZA 858456 B ZA858456 B ZA 858456B
Authority
ZA
South Africa
Prior art keywords
same
polypeptide
novel polypeptide
analgesic
chem
Prior art date
Application number
ZA858456A
Other languages
English (en)
Inventor
Hiroshi Yoshino
Yutaka Tsuchiya
Takeru Kaneko
Takahiro Nakazawa
Masuhiro Ikeda
Shin Araki
Kiyomi Yamatsu
Shinro Tachibana
Yoshihiro Arakawa
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ZA858456B publication Critical patent/ZA858456B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/675—Beta-endorphins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA858456A 1984-11-09 1985-11-04 Polypeptide ZA858456B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59236076A JPH0680079B2 (ja) 1984-11-09 1984-11-09 ポリペプチド

Publications (1)

Publication Number Publication Date
ZA858456B true ZA858456B (en) 1987-07-29

Family

ID=16995360

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA858456A ZA858456B (en) 1984-11-09 1985-11-04 Polypeptide

Country Status (21)

Country Link
US (1) US4707468A (en, 2012)
EP (2) EP0181001B1 (en, 2012)
JP (1) JPH0680079B2 (en, 2012)
KR (1) KR880000765B1 (en, 2012)
CN (1) CN1029684C (en, 2012)
AT (1) ATE135712T1 (en, 2012)
AU (1) AU588837B2 (en, 2012)
CA (1) CA1267997A (en, 2012)
DE (1) DE3588095T2 (en, 2012)
DK (1) DK171300B1 (en, 2012)
ES (1) ES8800272A1 (en, 2012)
FI (1) FI92935C (en, 2012)
GR (1) GR852689B (en, 2012)
HU (1) HU203563B (en, 2012)
IL (1) IL76924A (en, 2012)
NO (1) NO169347C (en, 2012)
NZ (1) NZ214122A (en, 2012)
PH (1) PH23847A (en, 2012)
PT (1) PT81441B (en, 2012)
SU (1) SU1433415A3 (en, 2012)
ZA (1) ZA858456B (en, 2012)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673376A1 (fr) * 1991-03-01 1992-09-04 Lefesvre Andre Composition pharmaceutique pour le traitement des tumeurs de kaposi.
US5817628A (en) * 1992-12-02 1998-10-06 The Rockefeller University Dynorphin a suppression of natural killer cell activity
SE9401596D0 (sv) * 1994-05-06 1994-05-06 Astra Ab New compounds
JP3385147B2 (ja) * 1996-01-31 2003-03-10 ユニ・チャーム株式会社 男性用尿とり袋
WO1997049422A1 (en) * 1996-06-24 1997-12-31 The Rockefeller University Method of using ligands of the kappa opioid receptor
NZ506839A (en) * 1998-03-09 2003-05-30 Zealand Pharma As Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
DE60131033T2 (de) * 2000-08-25 2008-07-17 Research Corp. Technologies, Inc., Tucson Verwendungen von antikonvulsiven Aminosäure zur Behandlung bipolarer Erkrankungen
PT1243262E (pt) * 2001-03-20 2006-10-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica
ES2185606T3 (es) * 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
US7622446B2 (en) * 2001-04-18 2009-11-24 The Open University Polypeptides, derivatives and uses thereof
US7491702B2 (en) * 2001-04-18 2009-02-17 The Open University Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
US8008351B2 (en) 2004-04-16 2011-08-30 Ucb Pharma Gmbh Methods for prophylaxis or treatment of conditions associated with cortical spreading depression
BRPI0514721A (pt) * 2004-08-27 2008-06-24 Sanol Arznei Schwarz Gmbh uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
GB2432586B (en) * 2005-11-25 2010-01-13 Univ Open Treatment of neurodegenerative disorders
ES2645529T3 (es) * 2006-06-15 2017-12-05 Ucb Pharma Gmbh Composición farmacéutica con efecto sinérgico anticonvulsionante
US20100184698A1 (en) * 2007-09-11 2010-07-22 Dorian Bevec Use of a deslorelin and mastoparan as a therapeutic agent
RU2010114017A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Терапевтическое применение натрийуретического пептида в-типа и гормона роста человека 1-43
EP3574892A4 (en) * 2017-06-14 2020-08-12 Bio Solution Co., Ltd. COSMETIC COMPOSITION TO REDUCE WRINKLES OR INFLAMMATION, CONTAINING SUBSTANCE P
TW201920234A (zh) 2017-09-11 2019-06-01 美商領導醫療有限公司 類鴉片促效劑肽及其用途
US20240301023A1 (en) * 2020-07-01 2024-09-12 PreveCeutical Medical Inc. Peptides and uses thereof
RU2760133C1 (ru) * 2021-04-22 2021-11-22 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства". Амиды гептапептида для лечения HMGB1-зависимых заболеваний

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254106A (en) * 1976-01-26 1981-03-03 Burroughs Wellcome Co. Biologically active amides
FR2338925A1 (fr) * 1976-01-26 1977-08-19 Wellcome Found Nouveaux peptides et medicament contenant ces substances
US4123523A (en) * 1976-06-21 1978-10-31 Imperial Chemical Industries Limited Analgesic and sedative polypeptides
US4371463A (en) * 1977-02-17 1983-02-01 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-resistant opiate pentapeptides
US4081434A (en) * 1977-03-11 1978-03-28 Hoffmann-La Roche Inc. Novel analogs of β-endorphin
US4127533A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel octapeptides, intermediates therefor, and compositions and methods employing said octapeptides
US4139504A (en) * 1977-06-16 1979-02-13 Coy David Howard Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
GB1604850A (en) * 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
US4148786A (en) * 1978-06-26 1979-04-10 American Home Products Corporation Analgesic polypeptide
US4178284A (en) * 1978-12-11 1979-12-11 American Home Products Corporation Octapeptides
DE2936099A1 (de) * 1979-09-06 1981-04-02 Victor Dipl.- Chem. 8000 München Brantl Pharmakologisch aktive peptide
EP0044451B1 (en) * 1980-07-17 1984-04-18 Sandoz Ag Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
JPS57134451A (en) * 1981-02-13 1982-08-19 Suntory Ltd Peptide opioide
EP0076676B1 (en) * 1981-10-05 1986-12-30 Tni Pharmaceuticals, Inc. Process for using endorphins as antitumour agents
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
JPS59141547A (ja) * 1983-02-01 1984-08-14 Eisai Co Ltd 鎮痛作用を有する新規ペプタイドおよび製法
US4518711A (en) * 1983-05-16 1985-05-21 Gibson-Stephens Institute Conformationally constrained cyclic enkephalin analogs with delta receptor specificity

Also Published As

Publication number Publication date
NO854435L (no) 1986-05-12
AU4938985A (en) 1986-05-15
EP0614913A3 (en) 1997-06-04
KR860004081A (ko) 1986-06-16
JPH0680079B2 (ja) 1994-10-12
NO169347B (no) 1992-03-02
FI854227L (fi) 1986-05-10
FI92935C (fi) 1995-01-25
JPS61115097A (ja) 1986-06-02
SU1433415A3 (ru) 1988-10-23
DE3588095T2 (de) 1996-09-19
ES548667A0 (es) 1987-10-16
EP0614913A2 (en) 1994-09-14
DE3588095D1 (de) 1996-04-25
CN85109722A (zh) 1986-10-08
DK513385A (da) 1986-05-10
EP0181001A2 (en) 1986-05-14
HU203563B (en) 1991-08-28
NZ214122A (en) 1988-08-30
IL76924A0 (en) 1986-04-29
ES8800272A1 (es) 1987-10-16
DK513385D0 (da) 1985-11-07
HUT40145A (en) 1986-11-28
CN1029684C (zh) 1995-09-06
AU588837B2 (en) 1989-09-28
US4707468A (en) 1987-11-17
IL76924A (en) 1990-07-12
FI92935B (fi) 1994-10-14
FI854227A0 (fi) 1985-10-28
NO169347C (no) 1992-06-10
EP0181001A3 (en) 1989-04-19
PH23847A (en) 1989-11-23
GR852689B (en, 2012) 1986-02-21
DK171300B1 (da) 1996-08-26
PT81441A (en) 1985-12-01
KR880000765B1 (en) 1988-05-06
EP0181001B1 (en) 1996-03-20
PT81441B (pt) 1987-11-11
CA1267997A (en) 1990-04-17
ATE135712T1 (de) 1996-04-15

Similar Documents

Publication Publication Date Title
ZA858456B (en) Polypeptide
AU643489B2 (en) Antibacterial agents - II
EP0074130A3 (en) New imidazole compounds, process for the preparation thereof and pharmaceutical compositions containing them
HUT41025A (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
AU568694B2 (en) N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine
EP0239105A3 (en) Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds
AU562271B2 (en) Pharmaceutical composition of corazepam and diphenhydramine
DE3469358D1 (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments
GR3019381T3 (en) 3-Anilino-2-hydroxycarbonyl-4-thiophen-acetic acids
GR3022259T3 (en) Tetrahydro-4-phenylimino-3-thiophen-acetic acids